1. (1) The number of individuals who have been screened through the Program;
2. (2) The types of tests used to screen those individuals;
3. (3) The costs of the tests; and
4. (4) The types of cancers detected by the tests.

On or before December 1, 2020, and each December 1 thereafter, the Department shall report, in accordance with § 2-1257 of the State Government Article, to the Senate Finance Committee and the House Health and Government Operations Committee on:

Added by Acts 2019, c. 219, § 1, eff. July 1, 2019. Amended by Acts 2019, c. 510, § 4; Acts 2019, c. 511, § 4.